Embecta Corp. (EMBCV)
NASDAQ: EMBCV
· Real-Time Price · USD
33.33
-3.43 (-9.33%)
At close: Apr 01, 2022, 6:00 AM
-9.33% (1D)
| Bid | n/a |
| Market Cap | 1.91B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 132,301 |
| Avg. Volume (20D) | 3,478,730 |
| Open | 40.42 |
| Previous Close | 36.76 |
| Day's Range | 33.33 - 38.21 |
| 52-Week Range | 27.20 - 49.00 |
| Beta | n/a |
About EMBCV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EMBCV
Website n/a
5 months ago · seekingalpha.com
Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In FavourEmbecta faces headwinds from new insulin delivery technologies and GLP-1 drugs, but its valuation is compelling with a ~44% free cash flow yield on guided free cashflow. EMBC's end market is expected ...